Dr. Paul BRADFIELD

Angestellt, CEO, Co-Founder, MesenFlow Technologies

Abschluss: Executive MBA, École Polytechnique Fédérale de Lausanne

Geneva, Schweiz

Werdegang

Berufserfahrung von Paul BRADFIELD

  • Bis heute 10 Jahre und 1 Monat, seit Juni 2014

    CEO, Co-Founder

    MesenFlow Technologies

    •Chief Operations & Business Development – A commercial bio-imaging platform service •Strategic Analysis & Market Research – Impact of translational in-vitro technologies in cosmetic and drug development •Oncology & Chronic Inflammation – Target discovery, development of translational medicine models •Financial & Operational Planning – Forecasts, throughput & budgetary due-diligence, risk analyses •MassChallenge Business Finalist 2016 ‘Top 10%’

  • 2 Jahre, Juni 2014 - Mai 2016

    Scientific Collaborator

    University of Geneva, Swizerland

    •Disease Modeling & Assay Development •Project Management & External Collaborations •Established new in-vitro/in-vivo technologies to study disease pathways in oncology & inflammation

  • 10 Monate, Aug. 2013 - Mai 2014

    Consultant

    Independent

    •Excel Modeling & Quantitative Drug Development Algorithms •Translational Medicine –Proprietary technology, support drug development in clinical medicine • Professional Proofreading of scientific documents & peer-reviewed articles • Business Intelligence – Collation of data, provision of analysis reports

  • 4 Jahre und 7 Monate, Juli 2008 - Jan. 2013

    Project Leader & Laboratory Head

    Merck Group

    Drug Discovery Project Team Leader: Biologic drug to treat inflammatory disease •Member of an International Joint Steering Committee (JSC) •Successful Delivery of Multiple Milestones - From concept to preclinical •Development & Management of a Bio-imaging Platform – Responsible for SOP, GLP validations •Team member & collaborator in development teams & programs

  • 6 Jahre und 6 Monate, Jan. 2002 - Juni 2008

    Scientific Collaborator

    University of Geneva

    • Funded by Novartis Travelling Scientist Award • Construction, supervision and management of the flow assay and bio-imaging facility • Sabbatical period (2006) – Harvard Medical School, Boston, USA. • Successful research portfolio – multiple publication in high quality peer reviewed journals

  • 4 Jahre und 11 Monate, Feb. 1997 - Dez. 2001

    Research Associate & PhD Student

    Univerisity of Birmingham

    • Completion of PhD in Rheumatology • Development of leukocyte-stromal cell retention translational models in chronic inflammation • Establishment of a cell bank for primary human fibroblast cell lines – now a recognized global repository

Ausbildung von Paul BRADFIELD

  • 1 Jahr und 5 Monate, Aug. 2013 - Dez. 2014

    Business Administration

    École Polytechnique Fédérale de Lausanne

    New Venture Strategy, Business Model, Business Plan, Finance, Marketing & Legal - IP - Strategic Alliances, Partnership & Outsourcing - Sales Management - International Negotiations, Business in China

  • 3 Jahre und 9 Monate, Apr. 1998 - Dez. 2001

    Rheumatology

    The University of Birmingham

Sprachen

  • Englisch

    Muttersprache

  • Französisch

    Gut

21 Mio. XING Mitglieder, von A bis Z